Hepatitis C - The Implications and The Need for Change in The Health Care System in Poland

• Autorzy: Jan Kobierski , Matuesz Hałdaś , Magdalena Władysiuk
• Języki publikacji: EN

Abstrakty

EN

Hepatitis C is a disease spreading across the world. It is estimated that more than 185 million people are potentially infected with HCV. Each year approximately 350 thousand people die of diseases resulting from HCV. In Poland about 231 thousand people are believed to be infected, with up to 85% of them unaware of their progressive illness. Hepatitis C leads to serious complications in the liver and, consequently, can lead to death. The disease generates appreciable costs associated with the treatment of the complications of HCV in the advanced stages of the disease as well as lost productivity. As there is no vaccine against HCV, hepatitis C treatment is the only way to eradicate the virus. This is now possible with new therapies. This article presents the burden of hepatitis C and its changing dynamics in the context of hepatitis B and HIV in Poland. The natural history, the costs generated by the disease, available current therapies and suggested ways forward are also discussed in the article(original abstract)

Słowa kluczowe

EN

Health care; Illness

PL

Opieka zdrowotna; Choroby

• Czasopismo: Journal of Health Policy and Outcomes Research
• Rocznik: 2014
• Numer: nr 2
• Strony: 26--34

Twórcy

autor

Jan Kobierski

• Jagiellonian University, Medical College, Krakow, Poland

autor

Matuesz Hałdaś

• HTA Consulting, Kraków, Poland

autor

Magdalena Władysiuk

• HTA Consulting, Kraków, Poland

Bibliografia

• Maasoumy B., Wedemeyer H. Natural history of acute and chronic hepatitis C. Best Pract Res Clin Gastroenterol. 2012; 26: 401-412
• Madaliński K., Flisiak R., Halota W. et al. Report prepared for The World Hepatitis Day - 28th July 2013; Available from: http://www.pzh.gov.pl/page/fileadmin/user_upload/aktualnosci/Report for Hepatitis Day WHO.pdf
• Madaliński K., Aktualny algorytm diagnostyki HCV; Available from: http://www.pzh.gov.pl/page/fileadmin/user_upload/SPPW/Konferencja_inauguruj ca_11.10.2012/Prezentacje/P2.ppt
• Gajewski P. Interna Szczeklika - mały podręcznik 2014/2015; Available from: http://www.mp.pl/interna/
• WHO. The 63rd World Health Assemby. Resolutions and Decisions Annexes; Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf
• European Parliament. Written Declaration submitted under Rule 123 of the Rules of Procedure on Hepatitis B and C; Available from: http://www.europarl.europa.eu/sides/getDoc.do?type=WDECL&reference=P7-DCL-2013-0023&language=EN&format=PDF
• WHO. Viral hepatitis. Report by the Secretariat. A63/15; Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_15-en.pdf
• Ly KN., Xing J., Klevens RM. et al. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156: 271-278
• Mühlberger N., Schwarzer R., Lettmeier B. et al. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health, 2009; 9: 34
• ECDC. Annual Epidemiological Report: Reporting on 2011 surveillance data and 2012 epidemic intelligence data; Available from: http://www.ecdc.europa.eu/en/publications/Publications/annual-epidemiological-report-2013.pdf
• Bogucki M. Diagnostyka i terapia przewlekłego wirusowego zapalenia wątroby typu C (wirusem HCV) w Polsce: raport - rekomendacje 2013-2014; Instytut Ochrony Zdrowia; Available from: http://www.gwiazdanadziei.pl/download/raport_komisji_zdrowia.pdf
• Zieliński A. Wirusowe zapalenie wątroby typu B i C w Polsce w latach 1993-2011; Available from: http://www.pzh.gov.pl/page/fileadmin/user_upload/SPPW/Konferencja_inaugurujaca/prezentacje/Prezentacja - HCV - projekty.pptx;
• TNS OBOP. Wiedza na temat wirusowego zapalenia wątroby. Raport z badania. Available from: http://www.gwiazdanadziei.pl/download/raport_wiedza_na_temat_wirusowego_zapalenia_watroby_tns_.pdf
• WHO. Guidelines for the screening, care and treatment of persons with hepatitis C infection; Available from: http://apps.who.int/iris/bitstream/10665/111747/1/9789241548755_eng.pdf?ua=1&ua=1
• Esteban JI., Sauleda S., Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol. 2008; 48:148-162
• Godzik P., Kołakowska A., Madaliński K. et al. Prevalence of anti-HCV antibodies among adults in Poland-results of cross-sectional study in general population. Przegla̧d Epidemiol. 2012; 66: 575-580
• Flisiak R., Halota W., Horban A. et al. Prevalence and risk factors of HCV infection in Poland. Eur J Gastroenterol Hepatol. 2011; 23: 1213-1217
• Prometeusze. Information about hepatitis B and hepatitis C; Available from: http://www.prometeusze.pl/19V/Informator_WZW.pdf
• Statement of the President of the National Health Fund.; Available from: http://www.nfz.gov.pl/new/index.php?katnr=0&dzialnr=2&artnr=2910&b=1&szukana=wirusowe 21.2.2013 ; [Accessed:17.10.2007]
• Godala M., Szatko F. Zgłaszalność chorób zakaźnych. Cz. I. Ocena świadomości lekarzy dotycząca zgłaszania chorób zakaźnych do inspekcji sanitarnej. Probl Hig Epidemiol. 2010; 91: 198-205
• NIPH - NIH. Infectious diseases and poisonings in Poland (annual reports); Available from: http://www.pzh.gov.pl/oldpage/epimeld/index_a.html
• ECDC. Surveillance and prevention of hepatitis B and C in Europe. European Centre for Disease Prevention and Control; 2010. Available from: http://ecdc.europa.eu/en/publications/Publications/101012_TER_HepBandC_survey.pdf
• Smith DB., Bukh J., Kuiken C. et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatol Baltim Md. 2014; 59: 318-327
• WHO. Hepatitis C. Global Alert and Responsis; Available from: http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index2.html

Identyfikatory

DOI

10.7365/JHPOR.2014.2.4